Research output per year
Research output per year
Fingerprint
Dive into the research topics where Teresa Calimeri is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 26 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots or
Research output
-
A dose-dense short-term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high-risk Burkitt lymphoma or high-grade B-cell lymphoma: safety and efficacy results of the “CARMEN” phase II trial
Ferreri, A. J. M., Cattaneo, C., Lleshi, A., Verga, L., Allione, B., Facchetti, F., Ponzoni, M., Foppoli, M., Ferrari, D., Rigacci, L., Pecciarini, L., Donadoni, G., Fumagalli, L., Sassone, M., Calimeri, T., Rossi, G., Spina, M. & Re, A., Jan 2021, In: British Journal of Haematology. 192, 1, p. 119-128 10 p.Research output: Contribution to journal › Article › peer-review
-
MATRix–RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial
International Extranodal Lymphoma Study Group (IELSG), Feb 2021, In: The Lancet Haematology. 8, 2, p. e110-e121Research output: Contribution to journal › Article › peer-review
Open Access -
Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B-cell lymphoma of the central nervous system – an international study of feasibility and efficacy in routine clinical practice
Schorb, E., Fox, C. P., Kasenda, B., Linton, K., Martinez-Calle, N., Calimeri, T., Ninkovic, S., Eyre, T. A., Cummin, T., Smith, J., Yallop, D., De Marco, B., Krampera, M., Trefz, S., Orsucci, L., Fabbri, A., Illerhaus, G., Cwynarski, K. & Ferreri, A. J. M., Jun 1 2020, In: British Journal of Haematology. 189, 5, p. 879-887 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation
Ferreri, A. J. M., Sassone, M., Angelillo, P., Zaja, F., Re, A., Di Rocco, A., Spina, M., Fabbri, A., Stelitano, C., Frezzato, M., Volpetti, S., Zambello, R., Rusconi, C., De Lorenzo, D., Scarano, E., Arcari, A., Bertoldero, G., Nonis, A., Calimeri, T., Perrone, S. & 6 others, , Aug 1 2020, In: Hematological Oncology. 38, 3, p. 257-265 9 p.Research output: Contribution to journal › Article › peer-review
-
Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation
Ferreri, A. J. M., Sassone, M., Angelillo, P., Zaja, F., Re, A., Di Rocco, A., Spina, M., Fabbri, A., Stelitano, C., Frezzato, M., Volpetti, S., Zambello, R., Rusconi, C., De Lorenzo, D., Scarano, E., Arcari, A., Bertoldero, G., Nonis, A., Calimeri, T., Perrone, S. & 6 others, , Aug 1 2020, In: Hematological Oncology. 38, 3, p. 257-265 9 p.Research output: Contribution to journal › Article › peer-review